MARKET

PHVS

PHVS

Pharvaris N.V.
NASDAQ
26.37
-1.32
-4.77%
Opening 11:57 12/05 EST
OPEN
27.60
PREV CLOSE
27.69
HIGH
27.92
LOW
26.14
VOLUME
115.24K
TURNOVER
--
52 WEEK HIGH
29.80
52 WEEK LOW
11.51
MARKET CAP
1.71B
P/E (TTM)
-7.6905
1D
5D
1M
3M
1Y
5Y
1D
Pharvaris Is Maintained at Outperform by Oppenheimer
Dow Jones · 22h ago
Oppenheimer Maintains Outperform on Pharvaris, Raises Price Target to $50
Benzinga · 22h ago
Pharvaris Stock Gains on HAE Drug Meeting Late-Stage Study Goals
NASDAQ · 22h ago
Pharvaris Is Maintained at Buy by Guggenheim
Dow Jones · 1d ago
Guggenheim Maintains Buy on Pharvaris, Raises Price Target to $39
Benzinga · 1d ago
Pharvaris Is Maintained at Overweight by Morgan Stanley
Dow Jones · 1d ago
Pharvaris (PHVS) Receives a Buy from Oppenheimer
TipRanks · 1d ago
Morgan Stanley Maintains Overweight on Pharvaris, Raises Price Target to $41
Benzinga · 1d ago
More
About PHVS
Pharvaris NV is a Netherlands-based company primarily engaged in the biopharmaceutical industry. The Company focuses on developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. Their key product is Deucrictibant (PHA121, PHA-022121), which is a small-molecule bradykinin B2 receptor antagonist. It is intended for both the on-demand and prophylactic treatment of HAE attacks. Deucrictibant has been studied in vitro, ex vivo, and in vivo models to assess its effectiveness in blocking the bradykinin B2 receptor. The Company is developing deucrictibant for on-demand use as PHVS416, a softgel capsule, and for prophylactic use as PHVS719, an extended-release tablet.

Webull offers Pharvaris NV stock information, including NASDAQ: PHVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHVS stock methods without spending real money on the virtual paper trading platform.